Peptide therapy 'personalization' claims: what the evidence actually shows

What did @stefanieraya actually say?

She documented her fifth injection of Mots-c, titrating to 60 units total across two syringes, taken fasted before a workout. Her stated goal: "to get rid of the visceral fat" she carries. She also said the peptide "helps with recovery," "helps with boosting your metabolism," and that it moves metabolic "pathways" faster. She framed the protocol as doctor-prescribed and personalized, which is worth noting given how often peptide content skips that part entirely.

To be clear about the dosing she described: she used two 50-unit syringes to administer what she describes as 130 units per side. That math deserves scrutiny, and we will get to it. But the core claims she is making are metabolic: fat loss, recovery support, and systemic metabolic activation.

Does the science back this up?

There is real, peer-reviewed biology behind Mots-c, but it is almost entirely preclinical. The honest answer is: promising in animal models, genuinely interesting in theory, and nowhere near proven in humans at the level her framing implies.

Mots-c is a mitochondrial-derived peptide first identified by Lee et al. (2015, Cell Metabolism). That paper showed it activated AMPK signaling in mice, improved insulin sensitivity, and reduced diet-induced obesity in rodents. A follow-up by Reynolds et al. (2021, Nature Aging) found that Mots-c levels in humans decline with age and that exogenous administration in aged mice improved exercise capacity and metabolic markers. That is legitimately interesting science.

What we do not have: randomized controlled trials in humans showing Mots-c injections reduce visceral adiposity. The leap from "this peptide exists in human mitochondria and works in mice" to "my fifth shot is targeting my visceral fat" is a significant one. AMPK activation does correlate with fat metabolism, but correlation in a mouse model is not a fat-loss protocol.

What did they get wrong (or right)?

She got the biology directionally right in a vague way. Mots-c does interact with metabolic pathways, and the AMPK mechanism is real. Pairing a peptide with exercise is also not crazy. There is some evidence, again mostly animal-based, that Mots-c's effects on glucose uptake are amplified by physical activity. Giving her credit for that.

What she got wrong, or at least oversimplified: presenting visceral fat reduction as a recognized claim of Mots-c rather than a hypothesis under investigation. Saying it "does increase your metabolic system" as a settled fact is a stretch. The dose math also raises questions. She describes 130 units per side for a total of 60 units total, then later says 130 on each side. The unit arithmetic in the video is inconsistent, which matters when discussing injectable, research-stage compounds. Dosing errors with peptides are not trivial.

• The visceral fat claim: plausible mechanism, zero human RCT evidence
• The recovery claim: no Mots-c-specific recovery data in humans
• The metabolism claim: supported by preclinical AMPK data, not clinical outcomes

What should you actually know?

Mots-c is not FDA-approved for any indication. It is not available as a commercially approved drug. Compounded versions exist in the gray zone of peptide therapy, and quality control across compounding pharmacies varies considerably. That is not a reason to panic, but it is a reason to demand transparency from whoever is prescribing it to you.

The creator mentions working with a doctor who personalizes her plan, which is genuinely the right approach for anyone exploring this space. But "personalized by a doctor" does not mean the compound has been validated for your specific goal. It means a licensed provider made a judgment call using incomplete evidence. That distinction matters.

If you are considering Mots-c, the questions worth asking your provider are: What compounding pharmacy sourced this, and do they have a certificate of analysis? What clinical endpoint are we tracking to know if this is working? What is the stopping criterion if it is not? Those are not questions that get asked enough in peptide content.

The bottom line

This video is more responsible than most peptide content on TikTok. She has a prescription, she mentions fasting and exercise context, and she is not claiming a cure. But the gap between "interesting mitochondrial peptide with mouse data" and "I am targeting my visceral fat" is wider than the video suggests. The science is early. The enthusiasm is running ahead of it.